These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22755159)

  • 1. [Immunotherapy targeting on Abeta for Alzheimer disease].
    Tabira T
    Nihon Rinsho; 2011 Dec; 69 Suppl 10 Pt 2():77-82. PubMed ID: 22755159
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's amyloid immunotherapy: quo vadis?
    Gandy S; Heppner FL
    Lancet Neurol; 2005 Aug; 4(8):452-3. PubMed ID: 16033686
    [No Abstract]   [Full Text] [Related]  

  • 3. Is the Abeta vaccine the answer?
    Bowen RL
    Neurobiol Aging; 2004; 25(5):617-8. PubMed ID: 15172739
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunotherapy for Alzheimer's disease targeting Aβ].
    Tabira T
    Nihon Rinsho; 2016 Mar; 74(3):423-6. PubMed ID: 27025080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.
    Schenk DB; Seubert P; Grundman M; Black R
    Neurodegener Dis; 2005; 2(5):255-60. PubMed ID: 16909006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Towards a vaccine against Alzheimer's?].
    Dodel R
    Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S18-20. PubMed ID: 24242033
    [No Abstract]   [Full Text] [Related]  

  • 7. [Amyloid-beta protein vaccine therapy for alzheimer's disease].
    Hara H
    Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):1122-8. PubMed ID: 16846064
    [No Abstract]   [Full Text] [Related]  

  • 8. Refining an Alzheimer's vaccine to avoid an inflammatory response.
    Brown ME; DaSilva KA; McLaurin J
    Expert Opin Biol Ther; 2005 Jun; 5(6):809-16. PubMed ID: 15952911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.
    Panza F; Frisardi V; Imbimbo BP; D'Onofrio G; Pietrarossa G; Seripa D; Pilotto A; Solfrizzi V
    Immunotherapy; 2010 Nov; 2(6):767-82. PubMed ID: 21091109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aβ42 gene vaccine for prevention and treatment of Alzheimer's disease].
    Rosenberg RN
    Rinsho Shinkeigaku; 2010 Nov; 50(11):838. PubMed ID: 21921464
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vaccine therapy for Alzheimer's disease].
    Hara H
    Nihon Rinsho; 2004 Apr; 62 Suppl 4():254-8. PubMed ID: 15174680
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization therapy for Alzheimer disease?
    Bennett DA; Holtzman DM
    Neurology; 2005 Jan; 64(1):10-2. PubMed ID: 15642896
    [No Abstract]   [Full Text] [Related]  

  • 13. Amyloid-beta vaccination for Alzheimer's dementia.
    McGeer PL
    Lancet; 2008 Oct; 372(9647):1381; author reply 1381-2. PubMed ID: 18940458
    [No Abstract]   [Full Text] [Related]  

  • 14. Current progress in beta-amyloid immunotherapy.
    Schenk D; Hagen M; Seubert P
    Curr Opin Immunol; 2004 Oct; 16(5):599-606. PubMed ID: 15342006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we prevent Alzheimer's disease?
    Almeida OP
    Braz J Psychiatry; 2005 Dec; 27(4):264-5. PubMed ID: 16358105
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccines: chasing the dream.
    Schnabel J
    Nature; 2011 Jul; 475(7355):S18-9. PubMed ID: 21760578
    [No Abstract]   [Full Text] [Related]  

  • 17. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
    Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
    Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines.
    Mandler M; Santic R; Gruber P; Cinar Y; Pichler D; Funke SA; Willbold D; Schneeberger A; Schmidt W; Mattner F
    PLoS One; 2015; 10(1):e0115237. PubMed ID: 25611858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine approach for Alzheimer's disease revisited.
    Frantz S
    Nat Rev Drug Discov; 2004 Sep; 3(9):726-7. PubMed ID: 15368652
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
    Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
    Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.